Predictive factors of conversion of clinically isolated syndrome to clinically definite multiple sclerosis

被引:0
|
作者
Kolcava, J. [2 ]
Vlckova, E. [1 ]
Pelisek, O. [1 ]
Kocica, J. [2 ]
Krkoska, P. [2 ]
Bednarik, J. [1 ]
机构
[1] Masaryk Univ, Fac Med, Brno, Czech Republic
[2] Univ Hosp Brno, Dept Neurol, Brno, Czech Republic
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
EPO-407
引用
收藏
页码:640 / 641
页数:2
相关论文
共 50 条
  • [1] Impact of cigarette smoking on conversion from clinically isolated syndrome to clinically definite multiple sclerosis
    Arikanoglu, Adalet
    Shugaiv, Erkingul
    Tuzun, Erdern
    Erakso, Mefkure
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2013, 123 (07) : 476 - 479
  • [2] Prognostic Factors for Conversion to Clinically Definite Multiple Sclerosis in an Italian Cohort of Subjects with Clinically Isolated Syndromes
    Portaccio, Emilio
    Lepore, Vito
    Hakiki, Bahia
    Zipoli, Valentina
    Lorenzo, Razzolini
    Comi, Giancarlo
    Trojano, Maria
    Amato, Maria Pia
    NEUROLOGY, 2010, 74 (09) : A66 - A66
  • [3] Prognostic factors for conversion to clinically definite multiple sclerosis in an Italian cohort of subjects with clinically isolated syndromes
    Portaccio, E.
    Lepore, V.
    Hakiki, B.
    Zipoli, V.
    Comi, G.
    Trojano, M.
    Amato, M. P.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S44 - S44
  • [4] Clinically isolated syndrome: diagnosis and risk of developing clinically definite multiple sclerosis
    Lopez-Gomez, J.
    Sacristan-Enciso, B.
    Caro-Miro, M. A.
    Pascual, M. R. Querol
    NEUROLOGIA, 2023, 38 (09): : 663 - 670
  • [5] A prospective study of the time to conversion to clinically definite multiple sclerosis in 172 Greek patients with clinically isolated syndrome
    Koutsis, Georgios
    Evangelopoulos, Maria Elephtheria
    Karachalios, Georgios
    Andreadou, Elisabeth
    Mandellos, Dimitris
    Vassilopoulos, Demetris
    Sfagos, Constantinos
    MULTIPLE SCLEROSIS, 2008, 14 : S72 - S72
  • [6] Risk factors for conversion to multiple sclerosis in patients with a clinically isolated syndrome
    Neuhaus, A.
    Guentner, M.
    Morrissey, S. P.
    MULTIPLE SCLEROSIS, 2007, 13 : S10 - S10
  • [7] Assessment of the risk of the transition of a monofocal clinically isolated syndrome to clinically definite multiple sclerosis
    Zakharov, A. V.
    Khivintseva, E. V.
    Poverennova, I. E.
    Gindullina, E. A.
    Vlasov, J. V.
    Sineok, E. V.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2013, 113 (02) : 28 - 31
  • [8] Treatment with glatiramer acetate delays conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome: subgroup analyses
    Comi, Giancarlo
    Carra, Adriana
    Fazekas, Franz
    Rieckmann, Peter
    Bajenaru, O.
    Hillert, Jan
    Elovaara, Irina
    Young, Carolyn
    Wynn, Daniel
    King, John
    Lubetzki, Catherine
    Hartung, Hans-Peter
    Myhr, Kjell-Morten
    Montalban, Xavier
    Komoly, Samuel
    Filippi, Massimo
    MULTIPLE SCLEROSIS JOURNAL, 2008, 14 : S38 - S38
  • [9] Conversion to definite multiple sclerosis in Turkish patients with clinically isolated syndromes
    Mutlu, M.
    Akman-Demir, G.
    Kurtuncu, M.
    Eraksoy, M.
    MULTIPLE SCLEROSIS, 2006, 12 : S167 - S168
  • [10] Treatment with glatiramer acetate delays conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome suggestive of MS
    Comi, G.
    Filippi, M.
    JOURNAL OF NEUROLOGY, 2008, 255 : 10 - 10